Bill Ackman

Bill Ackman

Last Update: 2014-11-21

Number of Stocks: 7
Number of New Stocks: 1

Total Value: $13,426 Mil
Q/Q Turnover: 2%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Bill Ackman' s Profile & Performance

Profile

William Ackman, co-investment manager for hedge-fund group Gotham Partners LP, formed Pershing Square in November 2003 with $54 million raised from three investors. Ackman got his start in the real estate business, where he worked for his father prior to starting Gotham.

Investing Philosophy

Bill Ackman is an activist investor. He buys the common stocks of public companies, and pushes for changes so that the market can realize the values of the companies. Ackman buys stocks trading at a discount, and sells when the companies reach their appraised value.

Total Holding History

Performance of Pershing Square LP fund

YearReturn (%)S&P500 (%)Excess Gain (%)
201029.715.0614.6
2008-13-3724.0

Top Ranked Articles

Bill Ackman Interview With Bloomberg
“Bank of America is attractive at the current price” Read more...
Competence, Margin of Safety or Financial Strength?
People are more likely to believe things they want to believe. At the same time people think that they are objective. A way to get out of this predicament is to look at the evidence and try to come up with a justification which would convince them that they should either reject the evidence or find a subset of evidence which is comforting. Read more...
Bill Ackman - Pershing Square 3Q 2011 Shareholder Letter; discussing JCP, FO, FBHS, FDO, GGP, C, CP
Dear Pershing Square Investor: Read more...
Gramercy Capital (GKK): A Graham Stock Wrapped in a Mystery
The investment analysis below is our twelfth in our series of guest posts, and is brought to you by friend of the blog PlanMaestro of the fantastic Variant Perceptions. We will keep the intro quick but safe to say we are honored to bring our readers Plan’s latest write-up on Gramercy Capital (GKK), which is as insightful and illuminating as we have come to expect from one of our favorite investors. In typical PlanMaestro fashion, we have decided to post the thesis in three parts, the first of which is below. Enjoy! Read more...
Bill Ackman's Full Presentation on the HKD
Bill Ackman gave a presentation yesterday at the Delevering Alpha Conference. Read more...
» More Bill Ackman Articles

Commentaries and Stories

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Herbalife after option expiry - Part II: counting shorts and longs Bill Ackman - Herbalife After Option Expiry - Part II: Counting Shorts And Longs
With Herbalife at $31 then any puts that Ackman has (and we know the prices of them) are in the money so far that their delta is almost one. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Herbalife after the January option expiry: Part 1 Bill Ackman - Herbalife After The January Option Expiry: Part 1
I have deliberately refrained from writing about Herbalife until the 17 January 2015 option expiry.We know from public disclosures that Pershing Square (PSQ) had a huge put option position on Herbalife.There were also a vast number of put options that expired on 17 January.Here are the outstanding in-the-money put contracts as at market close Friday. More...

  • Currently 1.00/5

Rating: 1.0/5 (1 vote)

Bill Ackman Says Benefits Of Oil Price Drop Outweigh Costs Bill Ackman - Bill Ackman Says Benefits Of Oil Price Drop Outweigh Costs
Bill Ackman (Trades, Portfolio)'s assets under management have grown from $11 billion to $18 billion over the past year. More...

Bill Ackman, Oil, Video


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

The Latest Bill Ackman Video On The Herbalife Pyramid Scheme Bill Ackman - The Latest Bill Ackman Video On The Herbalife Pyramid Scheme
The Bill Ackman (Trades, Portfolio) pursuit of Herbalife continues. More...

BILL ACKMAN


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Analysts Make Bullish Ratings in Response to Valeant’s Increased 2015 Guidance
Valeant Pharmaceuticals (NYSE: VRX) held a conference call with investors on Thursday, January 8, in which the company increased its guidance for 2015. Initially, Valeant had predicted $9.1 billion in revenue and $10 cash earnings per share for 2015. They increased estimates to $9.2 to $9.3 billion in revenue and $10.10 to $10.40 cash earnings per share. Shares spiked nearly 6.9% during intraday trading after the announcement, jumping from $145 to $155. More...

PHARMACEUTICAL, STOCKS, MERGERS AND ACQUISITIONS,


  • Currently 4.00/5

Rating: 4.0/5 (1 vote)

Love Him Or Hate Him, Bill Ackman Now Runs The World's Top Hedge Fund Bill Ackman - Love Him Or Hate Him, Bill Ackman Now Runs The World's Top Hedge Fund
Lunch was a bit awkward. It was around 1 p.m. on a warm October day in New York. A group of Wall Street investors were tucking into chicken in a red-wine demi-glace and Brussels sprouts at the Plaza Hotel. They’d convened for Jim Grant’s fall conference, hosted by the influential editor of Grant’s Interest Rate Observer. More...

hedge-fund, bill ackman


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Year End Review: Fast-Food Services
2014 was an eventful year for the fast-food service industry. Which restaurant chains came out ahead, and which ones trailed behind? More...

STOCKS


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Zoetis in a Growing Global Animal Health Industry
In this article, let's take a look at Zoetis Inc (ZTS), a $22.24 billion market cap company that is a global leader in the animal health products industry emerged as a separate entity following its spin-off from Pfizer (PFE) in June 2013. More...

  • Currently 4.63/5

Rating: 4.6/5 (8 votes)

The "Circle of Competence Trap" – Retail, Energy and Metal Sectors Warren Buffett,Bill Ackman - The
More...

JCP, TSCO, RSH, ARO, WARREN BUFFETT, BILL ACKMAN


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Ackman’s Pershing Square Buys Stake in Zoetis
Zoetis, Inc. (NYSE: ZTS) is an animal health company that produces vaccines for pets and livestock. Based in Florham Park, New Jersey, the animal health company was once a subsidiary of Pfizer (PFE) but became independent in February 2013. Bill Ackman (Trades, Portfolio), the philanthropic founder and CEO of Pershing Square Capital Management, bought an 8.5% stake in Zoetis for roughly $2 billion on November 11. Additionally, Zoetis released its third quarter report on November 4, topping analysts' expectations. More...

STOCKS, PFIZER, ZOETIS, ZTS, ACKMAN, PERSHING, CITIGROUP, MORGAN STANLEY


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Bob Olstein On 'Boring' Stocks Printing Money Bill Ackman - Bob Olstein On 'Boring' Stocks Printing Money
Bob Olstein, chairman and CIO of Olstein Funds, is known  as one of the leading experts in corporate disclosure and reporting practices. He wrote an incredible book, The Quality of Earnings, which helped push the use of forensic accounting techniques to identify certain factors in determining a company's future earnings power. (I highly recommend this book.) More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Activist Bill Ackman Buys Big Stake In Animal Healthcare Company Zoetis
I guess we shouldn’t be surprised that one of the more active activist investors is making another big move before the end of the year. More...

ACKMAN, ZTS


  • Currently 5.00/5

Rating: 5.0/5 (2 votes)

Bill Ackman's New Interview With Bloomberg
Summany Of Bill Ackman's (Trades, Portfolio) Interview With Bloomberg More...

BILL ACKMAN,VALUE INVESTOR,LONG-TERM,ACTIVIST INVESTOR,FANNIE,FREDDIE,


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Bill Ackman Discusses Herbalife and His New Investment Vehicle
From his newly-listed Amsterdam investment vehicle, Bill Ackman (Trades, Portfolio) has $6 billion in cash and already knows where he is going to investment. More...

Bill Ackman, Herbalife


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Ackman's Pershing Square Now Available To The Public Bill Ackman - Ackman's Pershing Square Now Available To The Public
Bill Ackman’s Pershing Square Holdings started trading on the Euronext Amsterdam under the symbol “PSH” on October 13. Daniel Loeb had a similar IPO in 2007 on the London Stock Exchange with his fund, Third Point Offshore (LSE:TPOU, LSE:TPOG, TPNTF). The goal of the IPO is to raise permanent capital to help the activist investor maintain his positions in target companies during times of turbulence. If too many investors have redemption requests in the hedge fund, the manager will not be able to maintain a position of control over all of the companies in the portfolio. More...

Bill Ackman, Pershing Square, IPO, Euronext Amsterdam


  • Currently 2.75/5

Rating: 2.8/5 (4 votes)

Bill Ackman's Midas Touch Bill Ackman - Bill Ackman's Midas Touch
Outside the investment community, the name of Bill Ackman (Trades, Portfolio) of Pershing Square might not raise as many eyebrows as the name of a guru like Warren Buffett (Trades, Portfolio), but Ackman’s track record is still impressive. He seems to have the Midas touch, even more of one than many of the gurus followed by GuruFocus. More...

Bill Ackman, Pershing Square, Burger King, Platform Specialty, Allergan, Air Products & Chemicals, Canadian Pacific Railway, Howard Hughes


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Bill Ackman and Valeant Could Sweeten Allergan Deal By $15 A Share
Bill Ackman (Trades, Portfolio) Pershing Square Capital and Valeant Pharmaceutical (VRX) are said to be planning to boost their offer to acquire Botox maker Allergan (AGN) by $15 a share. The enhancement offer marks the third increase to the original bid by Bill Ackman (Trades, Portfolio)'s Pershing Square Capital and Valeant. The latest increase in the bid is intended to keep Allergan from striking a rival deal. The bid by Pershing Square and Valeant could potenitally value Allergan at over $56 billion and if the duo's can it the deal with Allegan then the merger will be the largest of the year so far. More...

ALLERGAN MERGER, HOSTLE TAKEOVER,BILL ACKMAN,PERSHING SQUARE CAPITAL,LONG-TERM,


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Top Fund Managers See Massive Quote Losses In Their Stakes In Frannie and Freddie
Fairholme Fund's (Trades, Portfolio) and Perry Capital's cases were the most prominent and closely watched against the government over taking a 100% of Frannie (FNMA) and Freddie (FMCC) profits. They have lost their legal challenge to a change that the government made after the 2008 bailouts of Fannie and Freddie to send all of the firm's profits to the Treasury. Currently the government faces about 20 federal legal challenges brought by investors that have kept investors from participating in Fannie and Freddie's post-bailout profits. After a federal judge in the U.S. District Court for the District of Columbia dismissed Fairholme Fund's (Trades, Portfolio) and Perry Capital cases share for Fannie More...

FANNIE,FREDDIE,UNDERVALUED,PREFERRED SHARES,COMMON SHARES,


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Pershing Square Plans a $2 Billion Amsterdam Fund Public Listing
Activist fund manager Bill Ackman (Trades, Portfolio), founder of Pershing Square, hopes to raise at least $5 billion from institutional investors who aren't in the United States. His Pershing Square Capital Management is preparing for a public listing on the Amsterdam Stock Exchange. There are reports that the firm has already raised $1.5 billion from 30 of its core investors and currently have 300 investors. More...

BILL ACKMAN,PERSHING SQUARE,FUND LISTING,TWO BILLION,VALUE INVESTOR,ACTIVIST,CARL ICAHN,LONG-TERM,


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Hedge Fund Manager Bill Ackman with a Very Profitable Year Bill Ackman - Hedge Fund Manager Bill Ackman With A Very Profitable Year
In this article, let´s take a look at Bill Ackman (Trades, Portfolio), the man who is the founder and CEO of Pershing Square Capital Management LP, the hedge fund that has gained about 30% this year, well above the 2.5% hedge-fund industry average. More...

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Gm1
ReplyGm1 - 4 months ago
Dear Sirs / Madams,

I am so interested in Pershing Square, would you please advise me its performance and cost? Thank you.

GM
Samchell@yahoo
ReplySamchell@yahoo - 9 months ago
Some stocks are best evaluated by hands-on personal empiricism. After going into a Walgreen's store, it's manifestly clear where it ranks compared to CVS or Rite Aid. As for Ackman's attraction to Mondelez, perhaps he likes some of the company's snack items, and no doubt enough other consumers will share his taste to move the stock in a positive direction. But anyone looking for more something more dramatic would be better advised to take note of the population's compulsive consumption of Hershey products. (Twizzler's Twist 'n Pull Cherry Licorice is candy heroin.) Also, like Coke and Kleenex, Hershey's is a brand name that's synonymous with the product. (When's the last time your spouse asked you to go to Walgreen's to pick up a "Mondelez Bar"?) In short, investing is a game of guessing, supported by past predilections and indicators that "may" have a bearing on future results. But 50% of stock picking is playing hunches. Never ignore the intangibles as well as personal impressions--that's can't be charted or measured by most systems.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK